MFDS
- Status: likely_approved
🇰🇷 Hu1124 in South Korea
Hu1124 (EFALIZUMAB) regulatory status in South Korea.
Marketing authorisation
Hu1124 in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in South Korea
Frequently asked questions
Is Hu1124 approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Hu1124 in South Korea?
Roche is the originator. The local marketing authorisation holder may differ — check the official source linked above.